Authorised Independent Nu Skin Distributor

You've cleared the hardest stretch — the hot flashes, the night sweats, the sleep disruptions of the menopausal transition. But for millions of American women in postmenopause, the conversation doesn't end there. Once active symptoms resolve, the focus shifts to what clinicians call the "silent" consequences of sustained low estrogen: accelerated bone density loss, cardiovascular changes, and ongoing quality-of-life shifts that don't announce themselves with a hot flash. Estera® Phase III Women's Maintenance Formula ($64.00 / 30-day supply) is designed for exactly this stage — not symptom relief, but long-term maintenance of the systems most affected by postmenopause.
Best suited for: Postmenopausal women whose active symptoms have largely resolved and who want ongoing phytoestrogen support plus targeted bone and cardiovascular health nutrients.The menopausal transition and postmenopause represent two biologically distinct stages, and they call for different nutritional priorities. Phase II (the Transitions Formula) is formulated to manage the acute symptoms of fluctuating hormones. Phase III is built around a different premise: once estrogen has stabilized at its lower postmenopausal baseline, the body's most pressing concerns are no longer symptom-driven — they are structural and metabolic.
Sustained low estrogen accelerates bone turnover, shifting the balance away from bone formation and toward bone resorption — the underlying mechanism of postmenopausal osteoporosis risk. Simultaneously, cardiovascular risk profiles change as estrogen's cardioprotective effects diminish. Phase III's formulation philosophy reflects this shift: continued phytoestrogen support for hormonal balance, combined with targeted nutrients for bone and heart health — the two systems most affected by the long-term postmenopausal environment.
Soy isoflavones (including genistein and daidzein) are plant-derived compounds that interact with estrogen receptors and remain central to Phase III's formulation. In postmenopause, where endogenous estrogen is consistently low rather than fluctuating, research has examined whether long-term soy isoflavone intake may support bone mineral density. A 2013 meta-analysis published in Osteoporosis International (Taku et al.) found that soy isoflavone supplementation was associated with reduced bone resorption markers in postmenopausal women — making continued isoflavone intake a meaningful component of a post-transition maintenance approach rather than something to discontinue after symptoms resolve.
Phase III includes targeted co-factors specifically selected for the health priorities of postmenopausal women. Where Phase II prioritizes symptom modulation, Phase III integrates nutrients that address the structural and metabolic shifts of sustained postmenopause — supporting the two organ systems most affected by long-term low estrogen.
Phase III is not formulated for short-term use. Unlike supplements designed to address acute symptoms over weeks, Phase III is built for ongoing daily supplementation — reflecting the reality that postmenopause is not a temporary state but a permanent physiological shift requiring sustained nutritional support.
| Feature | Estera® Phase III | Thorne Meta-Balance | Garden of Life mykind Women 40+ |
|---|---|---|---|
| Primary Design Stage | Postmenopause maintenance (Phase III) | Peri/menopause symptom support | General women 40+ multivitamin |
| Phytoestrogen Source | Soy isoflavones (targeted postmenopausal dose) | Black cohosh extract (symptom-focused) | Not a primary ingredient focus |
| Bone Health Targeting | Specific co-factors for postmenopausal bone support | Not the primary formulation focus | General multivitamin mineral coverage |
| Stage-Specific Phasing | Part of a two-phase system (Phase II → Phase III) | Single-formula approach | Single-formula approach |
| Cardiovascular Support | Included as a postmenopausal priority | Not a stated primary focus | Included in broad multivitamin profile |
| Use Duration Design | Long-term daily maintenance | Ongoing, but symptom-oriented framing | Ongoing daily multivitamin |
Comparison based on publicly available product information. Formulation quality and ingredient selection differ significantly across products — consult your healthcare provider to evaluate which approach suits your individual postmenopausal health priorities.
Take daily with food as an ongoing maintenance supplement. Phase III is designed for long-term daily use post-menopause, not short-term symptom management. Consistent, sustained use aligns with the long-term nature of postmenopausal nutritional needs.
Yes. Estera® Phase III Women's Maintenance Formula ships from the official Nu Skin US warehouse. Delivery to the continental US typically takes 3–5 business days. Customers in Alaska and Hawaii may experience additional transit time. No membership is required to purchase.
Phase III is designed for women whose active menopausal symptoms — hot flashes, night sweats, significant sleep disruption — have largely resolved and whose primary health concern has shifted to long-term postmenopausal maintenance. The transition timing is individual. Discuss the right moment to switch with your healthcare provider, particularly if you are also managing bone density or cardiovascular health goals.
Potentially, but check for nutrient duplication — particularly with bone-supporting minerals — before combining. Consult your healthcare provider or a registered dietitian before stacking Phase III with other supplements to avoid excessive intake of any single nutrient.
Soy isoflavones interact with estrogen receptors, which means women with a personal or family history of hormone-sensitive conditions (such as certain breast or ovarian cancers) should consult their oncologist or gynecologist before use. Do not self-prescribe based on general supplement guidance alone.
Phase II (Transitions Formula) is formulated for the active menopausal transition — focused on managing symptoms driven by fluctuating hormones. Phase III shifts its nutrient profile to address the long-term consequences of sustained low estrogen in postmenopause: bone density maintenance, cardiovascular health, and continued phytoestrogen support without the acute symptom-management emphasis. The two formulas are complementary stages of the same system, not interchangeable.
No. Estera® Phase III is a dietary supplement, not a pharmaceutical intervention. It is not a replacement for medically prescribed hormone therapy (HRT/MHT). Women weighing the decision between supplemental support and prescription hormone therapy should work with their OB-GYN or menopause specialist to make an informed, individualized decision.
Please refer to the product label included with your shipment for complete serving size, capsule count, and dosage instructions. Nu Skin's official product page at nuskin.com provides the most current supplement facts panel.
Nu Skin operates its own manufacturing and quality control processes. For specific third-party testing certifications on this product, contact Nu Skin directly at nuskin.com or via their US customer support line for the most current quality assurance documentation.
Reviewed by the NuBest Skin Editorial Team. Last updated: May 2025.
*Independent Nu Skin Brand Affiliate — not produced or endorsed by Nu Skin Enterprises Inc.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
No registration needed — shop and purchase directly, no account setup required.
Shipped from official Nu Skin warehouse — 100% authentic, factory-sealed products with full warranty.
Competitive pricing — we offer great value on authentic Nu Skin products.

We fact-checked every clinical claim Nu Skin makes about the ageLOC LumiSpa iO — the 7x cleansing fi

The US supplement industry is worth $55 billion but loosely regulated. We examine what your multivit